Four questions to Luigi Naldini (San Raffaele Telethon Institute for Gene Therapy, Milan) about the Nature Biotechnology study that revealed limitations and risks of gene and prime editing.
Continue readingCRISPR patches: what to do when typos are the editor’s fault
Reply
CRISPeR FRENZY 